A potential Diamond-Blackfan anemia treatment swims into view

(Boston Children's Hospital) Zebrafish share about 70 percent of their genes with humans, and can be studied at a mass scale, enabling scientists to test hundreds, even thousands of drugs at a time simply by adding the drug to their water. One such test came up with a new potential treatment for a rare blood disorder, Diamond-Blackfan anemia (DBA): a drug called trifluoperazine, normally used to treat psychotic disorders. It's now in a clinical trial for DBA in adults.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news